The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as …
https://www.cnn.com/2020/09/15/health/covid-19-vaccine-trial-astrazeneca-nih-fda-kaiser/index.html